Stocks Health care PEN
NYSE · Health carePenumbra Inc (PEN)
Penumbra Inc brought in $1.6B of revenue over the twelve months to September 30, 2026, up 17.0% from a year earlier. Net income was $157M, a net margin of 10.1%. Operating cash flow minus capital spending left $174.9M of free cash flow in fiscal 2025. At September 30, 2026 it held $254.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 29, 2026.
Key facts about Penumbra Inc
- Net worth
- Penumbra Inc has a market value (market cap) of $12.7B at the latest share price, and shareholders' equity of $1.6B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $1.4B (+17.5% year on year), with net income of $177.7M. Over the 12 months to September 30, 2026: revenue $1.6B, net income $157M.
- Cash flow
- In fiscal 2025 operations brought in $238.7M of cash; after $63.7M of capital spending, free cash flow was $174.9M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 29, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Penumbra Inc's next report is expected around January 14, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Penumbra Inc does
Penumbra Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker PEN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.4B | $177.7M | $4.52 | $174.9M |
| 2024 | $1.2B | $14M | $0.36 | $147.3M |
| 2023 | $1.1B | $91M | $2.32 | $82.1M |
| 2022 | $847.1M | -$2M | -$0.05 | -$75M |
| 2021 | $747.6M | $5.3M | $0.14 | -$11.7M |
| 2020 | $560.4M | -$15.7M | -$0.44 | -$58M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where PEN ranks in Health care
Latest SEC filings
What Penumbra Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 6, 2026Passive stake changed SCHEDULE 13G/A
- October 29, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 16% to $410.1M versus the same quarter last year; diluted EPS $1.07 versus $1.17.
- October 29, 2026
- August 13, 2026Passive stake (5% or more) SCHEDULE 13G
- July 30, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 15% to $390M versus the same quarter last year; diluted EPS $0.88 versus $1.15.
- July 30, 2026
- June 22, 2026
- May 29, 2026
- May 7, 2026Form 425 filing 425
- May 7, 2026
What is PEN worth? A DCF from its reported cash flow
Insider trades
What the people running Penumbra Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 3 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 15, 2026 | Narayan ShruthiPresident | Shares withheld for tax | 1,367 | $439.1K |
| September 15, 2026 | Narayan ShruthiPresident | Shares withheld for tax | 1,230 | $391.7K |
| August 17, 2026 | Narayan ShruthiPresident | Received as pay | 3,060 | - |
| May 19, 2026 | Elsesser AdamCEO, Director | Gave as a giftindirect | 77,000 | - |
| April 2, 2026 | Grewal HarpreetDirector | Soldpre-planned (10b5-1) | 100 | $32.8K |
| March 15, 2026 | Roberts JohannaEVP, Gen. Counsel & Secretary | Shares withheld for tax | 186 | $62.5K |
| March 15, 2026 | Yuen MaggieChief Financial Officer | Shares withheld for tax | 186 | $62.5K |
| March 15, 2026 | Shiu LambertChief Accounting Officer | Shares withheld for tax | 150 | $50.4K |
Who owns PEN
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Vanguard Capital Management13G, passive | 5.07% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 451 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 4,297,555 | -32,901 |
| Hbk Investments L P | 1,838,508 | +204,247 |
| Vanguard Capital Management LLC | 1,709,877 | +15,389 |
| Vanguard Portfolio Management LLC | 1,667,276 | +12,799 |
| State Street Corp | 1,243,258 | +57,447 |
| ExodusPoint Capital Management, LP | 1,090,430 | +625,215 |
| Balyasny Asset Management L.P. | 1,090,163 | +328,067 |
| Jpmorgan Chase & Co | 1,071,454 | +668,835 |
| Goldman Sachs Group Inc | 847,104 | +126,529 |
| Arrowstreet Capital, Limited Partnership | 834,903 | +434,743 |
| Geode Capital Management, LLC | 796,471 | +1,023 |
| Norges Bank | 752,242 | new |
| UBS Group AG | 703,822 | +143,487 |
| Millennium Management LLC | 700,611 | -397,525 |
| Morgan Stanley | 591,824 | +190,468 |
| AQR Arbitrage LLC | 563,873 | +140,800 |
| Whitebox Advisors LLC | 506,881 | +61,880 |
| Capital World Investors | 479,701 | +28,886 |
| Citadel Advisors LLC | 448,763 | +246,038 |
| Neuberger Berman Group LLC | 438,553 | +134,932 |
Insiders
11 insiders reported holding 1,124,924 shares in total, about $361.6M at the last price.
| Holder | Shares |
|---|---|
| Elsesser AdamCEO, Director | 683,042683,042 held indirectly |
| Bose AraniDirector | 259,609258,462 held indirectly |
| Roberts JohannaEVP, Gen. Counsel & Secretary | 67,298 |
| Shiu LambertChief Accounting Officer | 39,323 |
| Narayan ShruthiPresident | 31,283 |
| Yuen MaggieChief Financial Officer | 18,167 |
| Grewal HarpreetDirector | 8,719 |
| Leeds JanetDirector | 6,639 |
| O'Rourke BridgetDirector | 5,962 |
| Sarna SurbhiDirector | 4,293 |
Questions about PEN
What does Penumbra Inc do?
Penumbra Inc is a company in the Health care sector, listed on NYSE as PEN. Its shares trade on NYSE under the ticker PEN.
What is Penumbra Inc's net worth?
Penumbra Inc has a market value (market cap) of $12.7B at the latest share price, and shareholders' equity of $1.6B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Penumbra Inc profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $157M on revenue of $1.6B, a net margin of 10.1%.
How much revenue does Penumbra Inc make?
Over the twelve months to September 30, 2026 Penumbra Inc reported revenue of $1.6B. That is 17.0% more than a year earlier.
When did Penumbra Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 29, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the passive stake changed from November 6, 2026.
When is Penumbra Inc's next earnings report?
Penumbra Inc's next report is expected around January 14, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare PEN with
Follow PEN
Get an email when Penumbra Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Penumbra Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.